scispace - formally typeset
L

Laurence Voutquenne-Nazabadioko

Researcher at Centre national de la recherche scientifique

Publications -  82
Citations -  985

Laurence Voutquenne-Nazabadioko is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: DPPH & Chemistry. The author has an hindex of 14, co-authored 64 publications receiving 669 citations. Previous affiliations of Laurence Voutquenne-Nazabadioko include Indian Council of Medical Research.

Papers
More filters
Journal ArticleDOI

Antimicrobial activities of flavonoid glycosides from Graptophyllum grandulosum and their mechanism of antibacterial action

TL;DR: The results of the present study indicate that the purified flavonoids from G. glandulosum possess antimicrobial activities, which are in some cases equal to, or higher than those of ciprofloxacin used as reference antibiotic.
Journal ArticleDOI

Triterpenoid Saponins From the Roots of Gypsophila Trichotoma Wender

TL;DR: The synergistic effect of the aminoacyl saponins, previously isolated from G. trichotoma, was tested for its ability to enhance the cytotoxicity of the targeted toxin in HER14 cells.
Journal ArticleDOI

Triterpenoid saponins from Symplocos lancifolia.

TL;DR: Three new bidesmosidic saponins and a new ursane triterpenoid, 2α,3β,11α,23-tetrahydroxyurs-12-en-28-oic acid, along with seven known compounds, were isolated from a methanolic extract of the leaves of Symplocos lancifolia.
Journal ArticleDOI

Antimicrobial and antioxidant flavonoids from the leaves of Oncoba spinosa Forssk. (Salicaceae)

TL;DR: The MeOH extract and compounds 2–5 were non-toxic to human red blood cells indicating their high selectivity to be used as antimicrobial and antioxidant drugs.
Journal ArticleDOI

Antimicrobial activities of saponins from Melanthera elliptica and their synergistic effects with antibiotics against pathogenic phenotypes

TL;DR: The present study showed significant antimicrobial activity of compounds 1, 2, 3 and 4 against the tested microorganisms, which could lead to new options for the treatment of infectious diseases and emerging drug resistance.